Adia Med has verified it has 361 round-lot shareholders, exceeding Nasdaq Capital Market's minimum requirement of 300 for an initial listing. This milestone is part of Adia Med's ongoing efforts to meet Nasdaq's listing standards, though other criteria like minimum bid price and financial tests remain. The company currently trades on the OTCQB and is pursuing a potential uplisting to Nasdaq. Adia Med specializes in regenerative medicine with active clinical studies and revenue from stem cell treatments and related products.
The US-Canada trade conflict escalated as President Trump threatened to ban Canadian airplane maker Bombardier from selling in the US, citing unfair trade practices. Canada responded with retaliatory tariffs on $20 billion of US goods, including stee...
1606 Corp. has signed a non-binding Letter of Intent (LOI) with EthosEnergy O&M to manage operations and maintenance of its planned 55 MW power facility in Lufkin, Texas, aimed at supporting data centers and AI applications. EthosEnergy O&M brings ex...
abrdn Global Infrastructure Income Fund (ASGI) maintains a Hold rating due to challenges in the utility and industrial sectors causing a decline in its net asset value (NAV). The fund offers a well-covered 12% yield, but distribution coverage may wea...
Québec Innovative Materials Corp. (QIMC) has started two large-scale, non-invasive 2D seismic surveys totaling about 78 line-kilometres to explore natural hydrogen in Québec and Nova Scotia. The 36 km survey in Québec is in partnership with the Témis...
Harmonic introduced cOS SensAI, a vendor-neutral software platform that integrates diverse broadband network data into a unified system to provide actionable insights. This tool helps broadband providers reduce operational complexity, improve custome...
